Nurami Medical has been accepted to the In-Ventech Growth Stage Program – a unique stratup program for post-pilot stage companies, backed
See Nurami Medical’s team at the 2022 CNS Annual Meeting in San-Francisco
Nurami Medical, which is developing a biodegradable surgical patch for Dura repair in neurosurgeries, has achieved its key endpoint in its clinical
Let’s meet at CNS 2022. Contact us to set up a meeting.
Nurami presented its novel technology at its booth and in a presentation given by Nurami COO, Dr. Amir Bahar.
As it nears commercialization, Noam Sorek, a seasoned BD executive, with experience in launching medical device sales in international markets, joins Nurami.
Entrepreneurial MedTech leader, Peter Stebbins joins Nurami’s team
Nurami Medical has recruited all the patients for a clinical trial on its product, ArtiFascia, a synthetic implant for restoring and repairing
Nurami Medical has recruited all the patients for a clinical trial on its product to repair soft tissue damaged during neurosurgery
Nurami Medical, a medical device R&D company, which is developing a groundbreaking technology that facilitates post-surgical healing of soft tissues, has